Insecticides India Ltd
INSECTICID NSE
Insecticides India Ltd
ChemicalsNSE: INSECTICID BSE: 532851 Pesticides & Agrochemicals
Key Fundamentals
MicrocapPesticides & AgrochemicalsChemicalsMarket Cap
₹1,879 Cr
Volatility
Moderate
P/E Ratio
13.52
EBITDA
₹239 Cr
Return on Equity
11.42%
Debt to Equity
0.13
Book Value
₹419.42
EPS
₹41.3
52W High
₹1,078.9
52W Low
₹518.6
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Insecticides India Ltd insights
58 extracted metrics + investor summaries across FY15–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Weaknesses
2- The company has delivered a poor sales growth of 8.55% over past five years.
- Company has a low return on equity of 12.0% over last 3 years.
Growth Rate
Revenue Growth
7.22% ↘
Net Income Growth
-1.83% ↘
Cash Flow Change
7.27% ↗
ROE
-12.76% ↘
ROCE
-9.26% ↘
EBITDA Margin (Avg.)
-2.37% ↘
Quarterly Results
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 302 | 640 | 696 | 358 | 272 | 657 | 627 | 358 | 359 | 691 | 638 | 385 | 426 |
| Expenses | 331 | 594 | 614 | 332 | 264 | 585 | 538 | 327 | 330 | 607 | 548 | 358 | 401 |
| Operating Profit | -29 | 46 | 82 | 26 | 9 | 72 | 90 | 31 | 28 | 85 | 89 | 27 | 25 |
| OPM % | -9% | 7% | 12% | 7% | 3.3% | 11% | 14% | 9% | 8% | 12% | 14% | 7% | 6% |
| Other Income | 0 | 4 | 0 | 1 | 5 | 3 | 2 | 0 | 3 | 4 | 3 | 1 | 5 |
| Interest | 4 | 3 | 3 | 3 | 2 | 2 | 2 | 1 | 2 | 4 | 4 | 5 | 4 |
| Depreciation | 7 | 7 | 7 | 7 | 8 | 7 | 7 | 8 | 7 | 7 | 9 | 9 | 9 |
| PBT | -39 | 40 | 72 | 17 | 4 | 66 | 82 | 22 | 22 | 77 | 79 | 14 | 16 |
| Tax % | -25% | 26% | 26% | 28% | -106% | 25% | 25% | 22% | 37% | 25% | 25% | 27% | 27% |
| Net Profit | -29 | 29 | 53 | 12 | 8 | 49 | 61 | 17 | 14 | 58 | 59 | 10 | 12 |
| EPS in Rs | -9.9 | 9.85 | 17.96 | 4.16 | 2.62 | 16.68 | 21.13 | 5.97 | 4.77 | 19.97 | 20.31 | 3.61 | 4.02 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 893 | 906 | 994 | 1,073 | 1,194 | 1,363 | 1,420 | 1,504 | 1,801 | 1,966 | 2,000 | 2,140 |
| Expenses | 782 | 814 | 882 | 925 | 1,006 | 1,207 | 1,268 | 1,333 | 1,679 | 1,804 | 1,779 | 1,913 |
| Operating Profit | 111 | 92 | 112 | 148 | 188 | 156 | 153 | 171 | 122 | 162 | 221 | 227 |
| OPM % | 12% | 10% | 11% | 14% | 16% | 11% | 11% | 11% | 7% | 8% | 11% | 11% |
| Other Income | 0 | 0 | 7 | 3 | 1 | 3 | -2 | 3 | 1 | 10 | 8 | 12 |
| Interest | 33 | 26 | 20 | 16 | 15 | 24 | 7 | 7 | 13 | 11 | 7 | 17 |
| Depreciation | 15 | 16 | 16 | 17 | 20 | 24 | 25 | 26 | 26 | 29 | 29 | 36 |
| PBT | 64 | 50 | 82 | 118 | 153 | 111 | 120 | 141 | 84 | 132 | 193 | 187 |
| Tax % | 14% | 21% | 27% | 29% | 20% | 22% | 21% | 24% | 25% | 23% | 26% | 25% |
| Net Profit | 55 | 40 | 60 | 84 | 123 | 87 | 94 | 107 | 63 | 102 | 142 | 139 |
| EPS in Rs | 19.24 | 12.77 | 19.26 | 27.19 | 39.62 | 28.04 | 30.29 | 36.29 | 21.36 | 34.49 | 48.81 | 47.91 |
| Div. Payout % | 0% | 10% | 7% | 5% | 3% | 10% | 4% | 6% | 14% | 9% | 4% | 4% |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 21 | 21 | 21 | 21 | 21 | 21 | 20 | 30 | 30 | 29 | 29 |
| Reserves | 278 | 388 | 444 | 527 | 641 | 711 | 800 | 850 | 889 | 982 | 1,056 | 1,191 |
| Borrowings | 322 | 206 | 237 | 114 | 305 | 191 | 100 | 54 | 163 | 87 | 105 | 157 |
| Other Liabilities | 308 | 321 | 277 | 338 | 388 | 372 | 505 | 473 | 615 | 620 | 709 | 623 |
| Total Liabilities | 920 | 936 | 978 | 1,000 | 1,356 | 1,294 | 1,426 | 1,396 | 1,696 | 1,719 | 1,898 | 2,000 |
| Fixed Assets | 210 | 198 | 185 | 232 | 240 | 239 | 239 | 253 | 263 | 286 | 282 | 370 |
| CWIP | 38 | 51 | 58 | 17 | 19 | 39 | 59 | 91 | 123 | 142 | 161 | 130 |
| Investments | 3 | 3 | 11 | 17 | 12 | 12 | 14 | 16 | 17 | 23 | 29 | 29 |
| Other Assets | 670 | 684 | 725 | 735 | 1,084 | 1,004 | 1,115 | 1,037 | 1,294 | 1,268 | 1,426 | 1,472 |
| Total Assets | 920 | 936 | 978 | 1,000 | 1,356 | 1,294 | 1,426 | 1,396 | 1,696 | 1,719 | 1,898 | 2,000 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | -6 | 86 | 4 | 182 | -133 | 242 | 155 | 135 | -11 | 187 | 93 | 100 |
| Investing | -34 | -19 | -14 | -26 | -49 | -24 | -113 | 9 | -86 | -46 | -38 | -86 |
| Financing | 36 | -64 | 9 | -143 | 172 | -159 | -104 | -115 | 80 | -98 | -61 | 18 |
| Net Cash Flow | -4 | 4 | 0 | 13 | -11 | 59 | -61 | 30 | -17 | 42 | -5 | 31 |
| Free Cash Flow | -40 | 67 | -10 | 154 | -171 | 213 | 108 | 68 | -97 | 143 | 59 | 8 |
| CFO/OP | 1 | 108 | 19 | 140 | -54 | 175 | 120 | 103 | 16 | 124 | 61 | 69 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 68 | 84 | 78 | 80 | 75 | 86 | 65 | 70 | 60 | 55 | 70 | 83 |
| Inventory Days | 220 | 190 | 232 | 214 | 355 | 202 | 248 | 228 | 247 | 221 | 268 | 215 |
| Days Payable | 118 | 114 | 108 | 128 | 141 | 96 | 136 | 117 | 128 | 115 | 154 | 121 |
| Cash Conversion Cycle | 170 | 159 | 201 | 166 | 289 | 192 | 177 | 181 | 178 | 161 | 185 | 177 |
| Working Capital Days | 40 | 75 | 80 | 93 | 116 | 98 | 108 | 111 | 92 | 97 | 106 | 105 |
| ROCE % | — | 12% | 16% | 20% | 21% | 14% | 15% | 16% | 10% | 13% | 17% | 16% |
Documents
1
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
13h - Insecticides India to meet B&K Securities Group and Trinity India Conferences on 29 May 2026 in Mumbai. 13h - Insecticides India to meet B&K Securities Group and Trinity India Conferences on 29 May 2026 in Mumbai.
2
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
30 Apr - Earning Call Intimation for Q4 & FY ended March 31, 2026 30 Apr - Earning Call Intimation for Q4 & FY ended March 31, 2026
3
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
30 Apr - Earning Call Intimation for Q4 & FY ended March 31, 2026 30 Apr - Earning Call Intimation for Q4 & FY ended March 31, 2026
4
Board Meeting Intimation for Intimation Of Board Meeting For Consideration Of Financial Results For The Quarter And Financial Year Ended March 31, 2026
16 Apr - Board meeting on 28 May 2026 to approve FY26 audited standalone and consolidated results. 16 Apr - Board meeting on 28 May 2026 to approve FY26 audited standalone and consolidated results.
5
Announcement under Regulation 30 (LODR)-Credit Rating
16 Apr - CRISIL reaffirmed Insecticides India’s long-term A+/Stable and short-term A1 ratings. 16 Apr - CRISIL reaffirmed Insecticides India’s long-term A+/Stable and short-term A1 ratings.
Frequently Asked Questions about Insecticides India Ltd
What does Insecticides India Ltd do?
Insecticides India is into manufacturing of agrochemicals (technicals and formulations) and biological and household products. They cater to Indian market where they directly sell to the end consumer and also sell technicals and formulations to the companies who are in the business of formulation...
Where is Insecticides India Ltd (INSECTICID) listed?
Insecticides India Ltd is listed on the Indian stock exchanges. It is listed on NSE: INSECTICID and BSE: 532851. You can view its live share price, financials, and ratios on Tapetide.
Which sector does Insecticides India Ltd belong to?
Insecticides India Ltd operates in the Chemicals sector within the Pesticides & Agrochemicals industry. Sector classification helps investors compare companies affected by similar economic conditions and regulatory changes.
What is the market capitalisation of Insecticides India Ltd?
Insecticides India Ltd has a market capitalisation of approximately ₹1878.70 Cr. Based on this, it is classified as a Small Cap stock.
What is the PE ratio of Insecticides India Ltd?
The Price-to-Earnings (PE) ratio of Insecticides India Ltd is 13.52. The PE ratio compares a company's share price to its earnings per share and is commonly used to assess whether a stock is overvalued or undervalued relative to its peers.
What is the 52-week high and low of Insecticides India Ltd?
Over the past 52 weeks, Insecticides India Ltd has traded between a low of ₹518.6 and a high of ₹1,078.9. This range helps investors understand the stock's price volatility and recent trading levels.
Does Insecticides India Ltd pay dividends?
Yes, Insecticides India Ltd has a dividend yield of 0.31%. Dividend yield indicates the annual dividend income relative to the share price. A consistent dividend history can signal financial stability.
What is the Return on Equity (ROE) of Insecticides India Ltd?
Insecticides India Ltd has a Return on Equity (ROE) of 11.42%. ROE measures how effectively a company uses shareholders' equity to generate profits. A higher ROE generally indicates better capital efficiency.
How can I research Insecticides India Ltd on Tapetide?
On Tapetide, you can view Insecticides India Ltd's live share price, quarterly results, profit & loss statements, balance sheet, cash flow, key ratios, shareholding pattern, technical indicators, analyst ratings, and forecasts — all on a single page without needing to sign up.
Company Information
Insecticides India is into manufacturing of agrochemicals (technicals and formulations) and biological and household products. They cater to Indian market where they directly sell to the end consumer and also sell technicals and formulations to the companies who are in the business of formulation. They also export to 30 countries with more than 100 customers through registrations. IIL has more than 75 registrations so far.[1]
Website insecticidesindia.com
CEO Mr. Hari Chand Aggarwal
Employees 1,729
Listed 2007-05-30
Face Value ₹ 10
Issued Size 2,90,97,837